CIF / Women’s & Maternal Health

Women’s & Maternal Health

Aqua, lavender, and white etched outlines of five women with different heights and body shapes, including a pregnant woman, on CIF blue.

Her health.
Her whole life.

From earlier diagnosis to safer birth and mental healthcare, women deserve solutions that meet them at every stage.

CIF backs founders addressing needs that conventional capital too often overlooks.

Explore the portfolio

The problem

Too important
to overlook.

Women’s health spans a lifetime. Maternal health is a critical part of that story. Both need more attention, access, and investment.

Women’s health

6%of private healthcare investment went to women’s health.Explore the context

World Economic Forum and BCG’s January 2026 report analyzed private healthcare investment from 2020–2025. This is private investment, not a share of all venture capital.

World Economic Forum / BCG, 2026
25%more time in poor health or disability for women than men.Explore the context

The 2026 Women’s Health Investment Outlook describes women’s greater lifetime burden of poor health and disability. This is a population comparison, not an individual prediction.

World Economic Forum / BCG, 2026

Maternal health

85.7%of reviewed pregnancy-related deaths were preventable.Explore the context

CDC’s 2022 Maternal Mortality Review Committee data: among deaths with a preventability determination. Missing or undetermined cases are excluded.

CDC, 2022 MMRC data
1 in 3U.S. counties are maternity care deserts.Explore the context

March of Dimes’ 2026 report finds 34.6% of counties and county equivalents lack obstetric clinicians and birthing facilities. Its national analysis includes Puerto Rico municipalities.

March of Dimes, 2026

Concrete examples / CIF portfolio

Where we put
capital to work.

Choose a health area, then a care priority. See the problem—and the companies building a way forward.

Care priority

Companies can connect to more than one care priority.

The problem

Earlier answers

Women need clearer answers when symptoms are overlooked or a diagnosis comes too late.

CIF portfolio / What they’re building

Explore the full Women’s & Maternal Health portfolio →

The CIF difference

Back the idea.
Build the path.

We bring philanthropic capital together with scientific, clinical, investment, operating, and patient perspectives. Our due diligence considers the need, the science, the team, and the work ahead.

When investments generate returns, we reinvest them in future health innovation.

See how CIF reviews investments →

Current opportunity / Maternal health

CIF Innovation Prize & Summit

For innovators developing better care—and better access to care—through pregnancy, birth, and postpartum.

CIF Innovation Prize in maternal health and Summit: $100,000 equity investment prize, February 2027 in New York City. Applications due December 11, 2026.

$100,000 equity investment prize

Applications due December 11, 2026
Summit February 2027 · New York City

Apply Now
CIF’s women’s health equity investment prize program at the 2026 Power of X Summit.
CIF at the 2026 Power of X Women’s Health Innovation Summit

Past women’s health events / 2025–2026

CIF brings
possibility together.

Our equity investment prize programs spotlight founders and connect them with capital, expertise, and a wider community. Cure’s Power of X provided the setting for our 2025 and 2026 women’s health programs.

Explore CIF’s past women’s health programs →
Follow CIF in the news →

Help the next idea reach patients

Make room
for what comes next.

Your support backs overlooked health innovation for women, mothers, and families.

Give to CIF

Apply Now

CIF Innovation Prize in maternal health and Summit: $100,000 equity investment prize. February 2027 in New York City. Applications due December 11, 2026.Apply for the $100,000 equity investment prize

Applications due December 11, 2026 · Summit February 2027 · New York City

Women’s Health by the Numbers

Women’s health remains under-researched and underserved across conditions and stages of life.

4 in 5

people diagnosed with an autoimmune disease are female.¹

In a Mayo Clinic study, more than

1/3 of midlife women

reported moderate, severe, or very severe menopause symptoms.²

1 in 8

mothers in the US experience symptoms of postpartum depression.³

Women make up almost

2/3

of Americans living with Alzheimers.⁴

Women were found to face a

20% increased risk

of developing heart failure or dying within five years after their first severe heart attack compared with men.⁵

Nearly

1 in 4

US students have struggled to afford period products.⁶

Women’s health is not a niche market—but it is still treated like one.

The gaps above show how often women’s health needs are overlooked: in research, diagnosis, treatment, and investment. Women make up more than half the population, yet women’s health companies receive only about 2% of U.S. healthcare venture capital funding.⁷ CIF responds by backing high-potential companies developing solutions across women’s and maternal health.

What CIF Donor Support Helps Build

CIF directs early capital toward founders and companies building in overlooked areas of women’s and maternal health.

51%

Women-led active portfolio

14

Women’s health companies

8

Maternal health companies

$1.85M

in impact investment funding for women’s health companies

CIF Equity Funding in Action

Through its regenerative funding model, CIF uses equity investments to support women’s and maternal health companies working to improve care, access, and quality of life. When investments generate returns, CIF can reinvest those proceeds into future health innovations. Our equity investment prizes help identify and spotlight promising founders, offering catalytic equity support and visibility to move transformative solutions closer to patients.

2026

DeepEcho

2026 Women’s Health Innovation Prize Winner

$100k equity investment prize

Expanding access to prenatal answers

DeepEcho is developing AI-enabled fetal ultrasound software that uses deep learning to support automated fetal measurements, teleguidance, remote diagnosis, and faster prenatal screening.

It is a validation of our approach and the work that we have done. The CIF team, who have seen thousands of startups, have seen our pitch, talked to me, asked me questions, and came away convinced that we were doing something meaningful. That is extremely valuable, and it is also going to drive other investors to join the round.
- Saad Slimani, Co-Founder of DeepEcho

Feminai

2026 Women’s Health Innovation Prize Runner-Up

$50k equity investment prize

Making breast health easier to check from home

Feminai is developing an at-home self-breast examination patch designed to make breast health screening more accessible, intuitive, and affordable—helping women check their breast health privately and comfortably from home.

This funding is another great signal that women are ready for innovation in their breast health solutions. Receiving validation from large crowds, mainly made up of women, shows us that our future users are anticipating our arrival to the market.
- Dr. Karny Ilan, Founder of Feminai

2025

LunaJoy Health

2025 Women’s Health Innovation Prize Winner

$100k equity investment prize

Mental health care for mothers

LunaJoy Health expands access to maternal mental health care, including support for postpartum depression and perinatal mental health needs.

When women get specialized treatment from providers trained specifically in reproductive psychiatry, we see an 80-percent decrease in post-hospitalization and a 27-percent improvement in medication adherence, and women get better faster because they engage in their treatment.
- Dr. Sipra Laddha, Co-Founder of LunaJoy Health

Limax Biosciences

2025 Women’s Health Innovation Prize Runner-Up

$50k equity investment prize + $50k CIF follow-on investment

Helping mothers survive severe bleeding

Limax Biosciences is developing biodegradable tough gel adhesives designed to seal and protect tissue even in wet, blood-filled environments.

Our mission is to transform standard of care, offering healthcare professionals and patients the tools needed to address tissue repair inside and outside the body. The power of Limax's biodegradable tough gel adhesives extends from minor superficial skin wounds to complicated post-surgery hemorrhages and traumas.​
- Dr. Benjamin Freedman, Co-Founder of Limax Biosciences

Flourish Care

2025 Women’s Health Innovation Prize Finalist

$100k CIF follow-on investment

More support before, during, and after birth

Flourish Care expands access to doulas, maternity support, and maternal care coordination.

When it comes to the birth of your baby, having the right support can make all the difference…Our mission is to improve the health and well-being of mothers, babies, and families by extending maternity care beyond the clinic and beyond the hospital and into the community.
- Melissa Bowley, Founder & CEO of Flourish Care

Other Portfolio Companies

Beyond CIF’s Innovation Prize recipients, our women’s health portfolio includes companies advancing solutions across diagnostics, care delivery, prevention, fertility, and treatment.

AOA Dx

Advancing earlier detection for ovarian cancer

Bloomer Tech

Turning everyday bras into heart health monitors

Cleerly

Detecting heart disease before a heart attack

Concarlo Therapeutics

Developing solutions for drug-resistant cancer

Dionysus Healthcare

Predicting postpartum depression risk before birth

Egal

Making period products as accessible as toilet paper

NUA Surgical

Making C-sections safer for mothers and babies

OCON Therapeutics

Delivering treatment through the uterus

PyrAmes

Tracking blood pressure for mothers and infants

Raydiant Oximetry

Improving fetal monitoring during childbirth

Media

CIF-supported women’s health innovation is gaining visibility across the broader healthcare and investment ecosystem.

In the News

2026 Power of X Summit: Key Takeaways

Cure’s recap explores the capital, care models, and research needed to advance women’s health innovation.


DeepEcho: 2026 CIF Equity Investment Prize

Meet DeepEcho, the 2026 CIF equity investment prize recipient advancing AI-enabled fetal ultrasound to expand access to prenatal care.


The Investment Case for Women’s Health

Leaders from investment, science, and healthcare make the case for stronger funding and research in women’s health.


LunaJoy: 2025 CIF Equity Investment Prize

Cure profiles LunaJoy, the 2025 CIF equity investment prize recipient, and its approach to mental health care for women.

Support this Work

Help CIF accelerate innovation in women’s health. Your support fuels equity investment prizes, follow-on investments, and early-stage companies working to improve care, access, and outcomes for women.

Sources

1. National Institutes of Health, “Understanding sex differences in autoimmune disease,” 2024.
2. Mayo Clinic, “Addressing Menopause Symptoms: Barriers and Opportunities for Improvement,”2025.
3. CDC, “Vital Signs: Postpartum Depressive Symptoms and Provider Discussions About Perinatal Depression – United States, 2018,” 2020.
4. Alzheimer’s Association, “Women and Alzheimer’s,” 2026.
5. American Heart Association, “Women found to be at higher risk for heart failure and heart attack death than men,” 2020.
6. Period, “Period Poverty,” 2026.
7. Deloitte, “Can investors help women’s health break through the glass ceiling?” 2024.
8. World Health Organization, “Breast Cancer,” 2026.
9. American Cancer Society, “Cancer Facts & Figures 2026,” 2026.